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Abstract Pim-1, a protooncogene product, is a serine/threonine
kinase and is thought to play a role in signal transduction in
blood cells. Few phosphorylated target proteins for Pim-1,
however, have been identified. In the present study, two-hybrid
screening to clone cDNAs encoding proteins binding to Pim-1
was carried out, and a cDNA for heterochromatin protein 1Q
(HP1Q) was obtained. Binding assays both in yeast and in vitro
pull-down using the purified HP1Q and Pim-1 expressed in
Escherichia coli showed that Pim-1 directly bound to the chromo
shadow domain of HP1Q. HP1Q was also associated with Pim-1
in human HeLa cells and the serine clusters located at the center
of HP1Q were phosphorylated by Pim-1 in vitro. Furthermore, a
transcription repression activity of HP1Q was further stimulated
by the deletion of the serine clusters targeted by Pim-1. These
results suggest that Pim-1 affects the structure or silencing of
chromatin by phosphorylating HP1.
z 2000 Federation of European Biochemical Societies.
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1. Introduction
The protooncogene pim-1 was identi¢ed as an activated
gene in T cell lymphoma induced by provirus insertion of
Molony murine leukemia virus [1]. Oncogenic activity of
pim-1 was assessed by the results of transgenic mice harboring
the pim-1 gene, that frequently brought about lymphoma [2].
Furthermore, synergistic oncogenecity between pim-1 and myc
was suggested by the fact that double-transgenic mice contain-
ing both genes induced lymphoma more e⁄ciently [3^6]. Pim-
1, the product of pim-1, is highly expressed in bone marrow,
spleen, thymus, lymph node and testis [3], and it is induced by
cytokines such as IL-3 or GM-CFS through the Jak2/STAT5
pathway, thereby implying that it plays roles in proliferation
or di¡erentiation of blood cells [7^14]. Two other proteins of
the Pim-1 family, Pim-2 [15,16] and Kid-1/Pim-3 [17,18], have
been identi¢ed, and Pim-1 or its family members were also
shown to be expressed in cells other than blood cells in a cell
cycle-dependent manner [19]. Since Pim-1 knockout mice did
not show signi¢cant disorders in tissues or cells, the physio-
logical functions of Pim-1 may be compensated by other Pim-
1 family proteins [20].
Pim-1 and its family proteins are a serine/threonine protein
kinase [21^27] and a putative target sequence for Pim-1 phos-
phorylation was suggested: (Arg/Lys)3-X-Ser/Thr*-XP for hu-
man Pim-1 [28,29]. p100 [30] and cdc25A [31] were recently
identi¢ed as target proteins for Pim-1 kinase. p100 is a nuclear
transpiration coactivator that stimulates c-Myb transcription
activity [30]. Although precise functions or other target pro-
teins of Pim-1 have not been clari¢ed, controversial roles of
Pim-1 in apoptosis induction or suppression have been re-
ported. Apoptosis induction was suppressed by Pim-1 in
pim-1 transgenic mice with an lpr/lpr background [32], where-
as ectopic introduction of Pim-1 to mouse NS-1-derived B
cells induced apoptosis in vitro [33]. Furthermore, pim-1
stimulated c-myc-induced apoptosis in Rat-1 cells by concom-
itant phosphorylation of cdc25A [31,34]. Although the rea-
sons for such discrepancy are not clear, it may be due to
di¡erent cell types or systems: the NS-1-derived B cells and
Rat-1 cells possess the intact Fas/Apo-1 gene, while the lpr/lpr
mice lacked the gene.
In this study, we identi¢ed heterochromatin protein 1 (HP1)
as a Pim-1 binding protein, and we found that HP1 was
phosphorylated by Pim-1 and that the transcriptional repres-
sion function of HP1 was partially abrogated by the deletion
of phosphorylation sites by Pim-1.
2. Materials and methods
2.1. Cells
Human 293T and HeLa cells were cultured in Dulbecco’s modi¢ed
Eagle’s medium with 10% fetal calf serum.
2.2. Plasmids
pGLex: HindIII^PstI fragment of pHybLex/Zeo (Invitrogen) was
inserted into the respective sites of pGBT9 (Clontech) in which the
fragment containing the GAL4 DNA binding domain (GALBD) and
multi cloning site had been deleted. The Cat-5 gene encoding a chlor-
amphenicol-resistant gene from pKF3 (Takara) was then inserted into
AatII^BglII sites of the above DNA. Generally, the restriction enzyme
site at the 5P or 3P end of Pim-1 or HP1 cDNA was changed to a site
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suitable for vector plasmids by PCR. An EcoRI^XhoI fragment con-
taining mouse Pim-1 was inserted into pGEX-6P-1 (pGEX-Pim-1),
pGLex (pGLex-Pim-1) and pcDNA-FLAG [35] (pcDNA3-F-Pim-1).
An EcoRI^PstI fragment containing Pim-1v2 was inserted into
pGLex (pGLex-Pim-1v2). An EcoRI^XhoI fragment containing HP1
or its deletion mutants was inserted into pGADGH (pGAD-HP1,
pGAD-HP1(v83^94), pGAD-HP1-N or pGAD-HP1-C), into
pGEX-6P-1 (pGST-HP1), into pcDNA3-hemagglutinin antigen
(HA) [36] (pcDNA3-HP1-HA) or into pcDNA-GAL4 [36] (pGA4-
HP1 or pGAL4-HP1(v83^94)). Details of the construction procedures
are available upon request.
2.3. Cloning of HP1 by a two-hybrid system
Saccharomyces cerevisiae L40 cells were transformed ¢rst with
pGLex-Pim-1v2, which did not activate lacZ transcription by itself.
The transformant cells were subsequently transformed with HeLa
MATCHMAKER cDNA (Clontech). Of approximately 4.7U105 col-
onies screened for lacZ expression, the plasmid DNAs in the lacZ-
positive cells were extracted by the procedure described in the proto-
cols from Clontech. The nucleotide sequence of plasmid derived from
a positive colony was determined and its encoding protein was char-
acterized.
2.4. In vitro binding assay
Glutathione-S-transferase (GST)-HP1 and GST were puri¢ed from
a 1000 ml culture of Escherichia coli BL21(DE3) transformed with
pGEX-HP1 and pGEX-6P-1, respectively, as described previously
[37]. 2 Wg of the puri¢ed GST-HP1 or GST was ¢rst applied to
GST-Sepharose 4B (Amersham-Pharmacia) in a bu¡er containing 20
mM Tris^HCl (pH 8.0), 150 mM NaCl, 0.5% NP-40 and 1 mM
EDTA. The 35S-labeled Pim-1 synthesized in vitro using pcDNA3-
Pim-1 as a template in the coupled transcription/translation system
(Novagen) was then applied to the column. After extensive washing of
the column with the same bu¡er as above, the proteins bound to the
resin were recovered, separated in a 12% polyacrylamide gel contain-
ing sodium dodecyl sulfate (SDS) and visualized by £uorography.
2.5. In vivo binding assay
1 Wg of pCMV-FLAG-Pim-1 together with 1 Wg of pCMV-HP1-HA
was transfected to human 293T cells 60% con£uent in a 10 cm dish
using Lipofect Amine plus (Gibco BRL). 48 h after transfection, the
whole cell extract was prepared by the published procedure [38]. Ap-
proximately 500 Wg of the 293T cell proteins was ¢rst immunoprecip-
itated with a mouse anti-FLAG antibody (M2, Kodak) in a bu¡er
containing 50 mM NaCl, 5 mM EDTA, 50 mM Tris (pH 7.5), 1 mg/
ml BSA, 150 Wg/ml PMSF and 0.25% NP-40. After washing with the
same bu¡er except for 0.05% NP-40 instead of 0.25%, the precipitates
were separated in a 12% polyacrylamide gel containing SDS, blotted
onto a nitrocellulose ¢lter, reacted with a mouse anti-HA antibody
12CA5 [39,40] or with the mouse anti-FLAG antibody.
2.6. Kinase assay
GST-HP1 or GST-HP1(v83^94) was expressed in E. coli and puri-
¢ed as described above. In vitro kinase reactions were carried out at
22‡C for 20 min in a mixture containing 250 ng of either GST-HP1 or
GST-HP1(v83^94), 2 Wg of GST-free Pim-1 and 10 WCi (3000 Ci/
mmol) of [Q-32P]ATP in 200 Wl of a kinase bu¡er (25 mM HEPES-
KOH (pH 7.5), 30 mM NaCl, 10 mM MgCl2 and 0.5 mM dithio-
threitol (DTT)). The reaction mixture was boiled in Laemmli bu¡er
and phosphorylated proteins were separated in a 12% polyacrylamide
gel containing SDS followed by autoradiography.
2.7. Luciferase assay
HeLa cells subcon£uent in a 6 cm dish were transfected with var-
ious amounts of e¡ector plasmids of pGAL4-HP1, pGAL4-HP1(v83^
94) or pGAL4 in addition to 1 Wg of pCMV-L-gal and 1 Wg of
p6UGAL4-SVP-Luc by the calcium phosphate precipitation method
[41]. 48 h after transfection, cell extracts were prepared by adding a
solution containing 25 mM Tris^phosphate (pH 7.8), 2 mM DTT,
10% glycerol, 1% Triton X-100 and 2 mM 1,2-diaminocyclohexane-
N,N,NP,NP-tetraacetic acid (Promega). After standardization of the
transfection e⁄ciencies by L-galactosidase assays, the luciferase activ-
ity was examined in the luciferase assay mixture supplied by Promega.
3. Results and discussion
3.1. Identi¢cation of HP1 as a Pim-1 binding protein and
determination of the Pim-1 binding region
To screen cDNAs encoding Pim-1 associating proteins,
Pim-1v2, an N-terminal fragment containing amino acid num-
bers 1^93, was fused to the LexA binding domain and intro-
duced to S. cerevisiae L40 cells. A human cDNA library pre-
pared from HeLa cells and cloned in pGADGH was then
introduced to the transformant yeast cells and the colonies
resistant to His marker followed by L-galactosidase expression
were selected. Among a total of 5U105 transformant cells, 18
colonies were His- and L-galactosidase-positive, and ¢ve of
the 18 positive colonies were identi¢ed as HP1Q [42] after
determination of their nucleotide sequences. Since the longest
clone lacked three nucleotides, ATG for the ¢rst methionine,
an oligonucleotide of ATG was attached to the N-terminus of
this clone and used as a wild-type HP1Q. All the clones of
HP1Q obtained, wt, v1, v10, v23 and v89, contained the
same region from amino acid #90 to polyA (Fig. 1). Because
the published sequence of HP1Q lacked the 3P untranslated
region [42], all the sequences of our clones were determined
(accession number AB030905). HP1Q was comprised of at
least three domains, chromodomain, serine cluster and chro-
mo shadow domain, all of which were thought to be impor-
tant domains for function (see review [43,44]).
Fig. 1. Determination of the HP1Q region bound by Pim-1. The wild-type (wt) or various deletion mutants of HP1Q were fused to GALAD
and used for the yeast two-hybrid assays in L40 cells pretransformed with LexBD-Pim-1v2. After incubation on ¢lters, the L-galactosidase ac-
tivity was assayed.
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To assess the Pim-1 binding region of HP1Q, various dele-
tion constructs fused to the GAL4 activation domain (GAL-
AD) were used for a two-hybrid assay with Pim-1v2 as a bait
(Fig. 1). Except for HP1Q-N containing amino acid from #1 to
90, all other clones, including the original clones isolated,
bound to Pim-1, and deletion of the region from #83 to 90
within the serine cluster gave a stronger signal for binding to
Pim-1v2 than that of the wild-type. These results indicate that
Pim-1 binds to the C-terminal half region of HP1Q including
the chromo shadow domain. An in vitro binding assay was
then performed by using puri¢ed GST-HP1Q and 35S-labeled
Pim-1 synthesized in vitro (Fig. 2A). Labeled Pim-1 bound to
GST-HP1Q, but not GST, indicating a direct interaction be-
tween HP1Q and Pim-1. To see a complex formation of HP1Q
with Pim-1 in vivo, expression vectors for FLAG-tagged Pim-
1 and HA-tagged HP1Q alone or together were transfected to
human 293T cells. 48 h after transfection, the cell extract was
prepared and the proteins in the extract were ¢rst immuno-
precipitated with an anti-FLAG antibody. The precipitates
were divided in two aliquots, and each of the precipitates
was immunoblotted against either the anti-FLAG antibody
or an anti-HA antibody (Fig. 2B, left or right, respectively).
The anti-FLAG antibody did precipitate FLAG-Pim-1 under
the condition where the same levels of immunoglobulin light
chain were precipitated in all the samples (Fig. 2B, left, lanes 2
and 3). HP1Q-HA, on the other hand, was only detected in the
immunoprecipitate from cells transfected with both FLAG-
Pim-1 and HP1Q-HA (Fig. 2B, right, lanes 2^3), indicating
that HP1Q was associated with Pim-1 in ectopic-expressed
293T cells.
3.2. Phosphorylation of HP1Q by Pim-1
Since Pim-1 is a serine/threonine protein kinase and its con-
sensus sequence is well-matched with the amino acid sequence
around a serine cluster in HP1Q, 80KRKSLSDSESDDSKS94,
it is possible that HP1Q is phosphorylated by Pim-1. To this
end, GST, GST-wild-type HP1Q and GST-Pim-1 were puri¢ed
from the expressed E. coli and then GST-free Pim-1 was pre-
pared after the digestion of GST-Pim-1 with PreScission pro-
tease. Both GST-HP1Q and Pim-1 were incubated with [Q-
32P]ATP and the labeled proteins were separated on the gel
(Fig. 3). Pim-1 was autophosphorylated irrespective of the
presence or absence of substrate protein and GST-wild-type
HP1Q, but not GST, was phosphorylated with Pim-1 (Fig. 3,
lanes 1^5). A kinase-negative mutant of Pim-1 in which lysine
at amino acid #67 was changed to methionine did not phos-
phorylate GST-HP1Q (data not shown). We then constructed
mutant HP1Q by deleting serine clusters from amino acid #83^
94 and used it for the kinase assay. The results clearly showed
that GST-HP1(v83^94) was phosphorylated by Pim-1 at 1/20
the e⁄ciency of that of wild-type HP1Q (Fig. 3, lanes 6 and 7).
When each of six serines in this cluster of HP1Q was substi-
tuted for alanine and used for the kinase assay, phosphoryla-
tion of each mutant of HP1Q was marginally, but not com-
pletely, decreased (data not shown). These results suggest that
Fig. 2. In vitro and in vivo binding assays between Pim-1 and HP1Q. A: In vitro binding assay between Pim-1 and HP1Q. GST or GST-HP1Q
was expressed in E. coli BL21(DE3) and applied to GST-Sepharose 4B. [35S]Pim-1 synthesized in vitro in a coupled transcription/translation
system was then applied to the column. The labeled proteins bound to the column were separated in a gel and visualized by £uorography. 1/50
Volume of the labeled Pim-1 used for the binding reaction was applied in the same gel (lane 1). B: Association of Pim-1 with HP1Q in human
293T cells. Pim-1 and HP1Q were tagged with either FLAG or HA, and their expression vectors alone or together were introduced to human
293T cells. Two days after transfection, cell extracts were prepared and the proteins in the extracts were ¢rst immunoprecipitated (IP) with an
anti-FLAG antibody. The proteins in the precipitates were separated in a 12% polyacrylamide gel and blotted with the anti-FLAG (left panel)
or an anti-HA antibody (12CA5) (right panel). 1/10 Or 1/50 volume of the extract used for the binding reaction was applied in the same gel
(Input, lane 1 in left and right panel, respectively).
Fig. 3. Phosphorylation of HP1Q by Pim-1. GST by itself and GST
fusion proteins of HP1Q or HP1Q(v83^94) were expressed in E. coli,
puri¢ed and incubated in various combinations in the presence of
[Q-32P]ATP and GST-free Pim-1. Labeled proteins bound to the res-
in were then separated in a 12% polyacrylamide gel and autoradio-
graphed.
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six serines in the cluster of HP1Q are target sites for phosphor-
ylation by Pim-1 and that these serines mutually a¡ect their
phosphorylation states.
3.3. E¡ect of serine clusters on transcriptional repression
activity of HP1Q
HP1 was identi¢ed as a protein involved in position-e¡ect
variegation in Drosophila and a component of a transcription-
al repression complex [43^47]. Controversial results about
DNA binding activity of HP1 have been reported [48,49].
We therefore tested the transcriptional repression activity of
HP1 in the GAL4 system as reported [46,47]. Expression vec-
tor of HP1Q fused to GALBD was cotransfected to HeLa cells
with 6UGAL4 fused to the SV40 promoter linking to the
luciferase gene, and the luciferase activity was measured 48
h after transfection (Fig. 4). While the GAL4 DNA binding
domain alone did not a¡ect luciferase activity, GAL4-HP1Q
repressed luciferase activity in a dose-dependent manner, in-
dicating that this system was suitable to see the transcriptional
repression activity of HP1. Then an HP1Q mutant in which a
serine cluster had been deleted, HP1Q(v83^94), was fused to
GALDB and its transcription activity was similarly tested.
The result showed that transcriptional repression activity
was enhanced by 15^20% compared to that of wild-type
HP1Q (Fig. 4A). Since a putative nuclear localization signal
of HP1 is present in a deletion containing amino acid 83^94,
the e¡ect of the deletion on the repression activity of HP1
might be due to di¡erent locations of two proteins fused to
the GAL4 DNA binding domain. This possibility, however,
was ruled out by the nuclear localization of both proteins
after transfection (Fig. 4B). These results suggest that the
transcriptional repression activity of HP1Q might be in£uenced
by its phosphorylation state catalyzed by Pim-1.
HP1 is a heterochromatin-associated protein well-conserved
from yeast to man. Genetic analysis of HP1 in yeast and
Drosophila revealed that HP1 plays roles in position e¡ect
variegation and in silencing chromatin [43^45]. In the present
study, we found that Pim-1 bound to the chromo shadow
domain of HP1Q to be phosphorylated. The chromo shadow
domain of human HP1 was reported to be essential for tran-
scriptional repression activity of HP1, to which SP100, a com-
ponent of a transcriptional repression complex, bound [46,47].
It is therefore worth testing whether Pim-1 is also involved in
this transcriptional repression complex. HP1 is a highly phos-
phorylated protein and at least a cdc2-like kinase participated
in HP1 phosphorylation in Tetrahymena [50]. After deletion of
a serine cluster located at the center of human HP1Q, the
amount of phosphorylated HP1Q by Pim-1 was reduced to
1/20 of that of wild-type of HP1Q, suggesting that other ser-
ine/threonine(s) are also phosphorylated by Pim-1. Although
it is possible that kinases other than Pim-1 are also respon-
sible for human HP1 phosphorylation, as in Tetrahymena,
the fact that the deletion of a serine cluster from HP1Q stimu-
lated a transcription repression activity of HP1Q suggests neg-
ative regulation of HP1Q function by Pim-1 phosphorylation.
Taken together, these results suggest a new function of Pim-1
that may be involved in a certain aspect of chromatin dynam-
ics.
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